Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class - Articles - Neurology · Psychiatry

Migraine and Headache

Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients

Neurol Sci.

Fekrazad R, Sardarian A, Azma K, Karami M, Borhani-Haghighi A, Gharesi-Fard B, Movahedi B

doi: 10.1007/s10072-018-3340-3.

RECOMMENDED

Migraine and Headache

Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine

N Engl J Med.

Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, Dubowchik GM, Conway CM, Coric V, Goadsby PJ

doi: 10.1056/NEJMoa1811090.

Migraine and Headache

Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial

JAMA Neurol.

Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, Ashina M

doi: 10.1001/jamaneurol.

Migraine and Headache

Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study

Headache

Kawata AK, Shah N, Poon JL, Shaffer S, Sapra S, Wilcox TK, Shah S, Tepper SJ, Dodick DW, Lipton RB

doi: 10.1111/head.14053

COMMENTED

Migraine and Headache

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab

Cephalalgia.

Buse DC, Lipton RB, Hallström Y, Reuter U, Tepper SJ, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA

doi: 10.1177/0333102418789072.

Migraine and Headache

CGRP and the Trigeminal System in Migraine

Headache.

Iyengar S, Johnson KW, Ossipov MH, Aurora SK

doi: 10.1111/head.13529.

Migraine and Headache

Novel Medications for the Treatment of Migraine

Headache.

Ceriani CEJ, Wilhour DA, Silberstein SD

doi: 10.1111/head.13661.

Migraine and Headache

Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions

Cephalalgia.

Ashina M, Kudrow D, Reuter U, Dolezil D, Silberstein S, Tepper SJ, Xue F, Picard H, Zhang F, Wang A, Zhou Y, Hong F, Klatt J, Mikol DD

doi: 10.1177/0333102419888222.

Migraine and Headache

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine

Headache.

Winner PK, Spierings ELH, Yeung PP, Aycardi E, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y

doi: 10.1111/head.13654.

Related content

Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients

Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine

Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial

Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab

CGRP and the Trigeminal System in Migraine

Novel Medications for the Treatment of Migraine

Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine